Classifications

• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
  • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
  • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
• • C—CHEMISTRY; METALLURGY
  • C40—COMBINATORIAL TECHNOLOGY
  • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
  • C40B30/00—Methods of screening libraries
  • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
  • G01N33/54306—Solid-phase reaction mechanisms
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q1/6813—Hybridisation assays

Definitions

• This disclosure provides for devices and methods for conducting assays for large scale combinatorial libraries.
• the devices and methods disclosed herein allow for conducting simultaneous assays on libraries of up to ten million compounds.
• Combinatorial libraries are well known in the literature and often utilize beads. Each of these beads contain multiple copies of a single compound bound by a linker to the bead. In addition, the bead typically contains a reporting element such as DNA that allows for assessing the structure of the single compound on the bead. Many of these libraries are limited by the fact that the compound being tested remains on the bead during the assay. As such, the biological data generated by the assay is potentially compromised by the possibility that the bound compound is not able to effectively bind to the target of choice. This could be due to physical interference from the bead as well as possible steric interference due to the attachment of a linker connecting the compound to a bead. As to the latter, this linkage could inhibit the ability of an otherwise potent compound from binding properly to the target, resulting in assay results that evidence less than the actual potency of the compound.
• One option for addressing this problem includes the use of cleavable linkers that cleave under proper stimulation (e.g., light) thereby freeing the compound from the bead. Once the compound is in solution, such as in a test well, it is free to orient itself in a manner that provides maximum potency in the assay. Still further, release of these compounds can be conducted in a manner such that the amount of compound released is controlled so as to provide meaningful dose dependent data. See, e.g., US Patent Application Pub. No. 2019/0358629.
• the former can occur when the test compound in solution is active and a portion of that solution “spills-over” to a test well with an inactive compound.
• the spill-over results in the well with the inactive compound now having active compound which then erroneously reports that there is activity in that well.
• the latter can occur when spill-over from a well with an inactive compound contaminates a well with an active compound and reduces the concentration of the active compound such that the reported activity is less than the actual activity when reported in a dose-dependent manner.
• the spill-over problem is particularly relevant when the assay device contains a large number of wells in close proximity to each other.
• well density is increased to the point that aqueous solutions in one well can spill over and contaminate an adjacent well.
• the assay results become less reliable with individual well reliability decreasing with increasing well density. This creates a conundrum for the technician - either use an assay device that separates the well by such a distance that it no longer can accommodate a desired well density, or allow for spill-over that reduces the reliability of the data generated during the assay.
• each well in an assay device comprises a target which is the intended binding site of the test compound.
• the target location is preferably at or near the center of the well.
• the target is a viable cell, after deposition, the cell can translocate into the comer of the well where visualization of these cells becomes more difficult.
• the assay results are often measured by visualizing the cell, the failure to properly visualize is a significant drawback on the ability of the assay to convey reliable information regarding the activity of cells.
• this disclosure provides for an assay device containing a high density of wells that is configured to inhibit spill-over of a portion of an aqueous solution from a first well into a second well.
• this disclosure provides for an assay device that impedes translocation of a target, such as a viable cell, positioned in a well. For example, impeding translocation of a target can reduce the risk of the target translocating to a site within the well that is difficult to reliably detect the resulting biological consequences of the soluble compound being absorbed into the cell.
• an assay device (1) comprising a high density of wells (2) aligned thereon wherein each of said wells (2) comprises: a) a floor wall (8) and side walls (7) that are configured to retain one or more beads (6) and one or more targets (16) in an aqueous solution (17); and b) partitions (3) separating adjacent wells (2) from each other provided that each of said partitions is at least about 10 microns in length from the nearest edge of a first well (2) to the nearest edge of a second well (2') wherein said second well (2') is the nearest neighbor from the first well (2); wherein at least a surface portion of said partitions (3) comprises a hydrophobic water repellant layer (4) that is incorporated therein and encompasses the surface thereof or extends from the surface thereof.
• a well of the device (2) contains one or more beads (6) each of which contains multiple copies of a single compound which are releasably bound to said bead(s) (6) in a dose dependent manner.
• said floor wall (8) comprises a target capturing element (5) that captures said target (16) and which is capable of impeding target movement within the well (2) after placement of the target (16) therein.
• one or more of said beads further comprises a mRNA capturing component.
• an assay device (1) comprising a high density of wells (2) aligned thereon wherein each of said wells (2) comprises: a) a floor wall (8) and side walls (7) that comprises one or more beads (6) and one or more targets (16) in an aqueous solution (17) wherein the bead or beads (6) in an individual well (2) contains multiple copies of a single compound which are releasably bound to said bead(s) (6) in a dose dependent manner and further wherein each of said beads (6) comprises a mRNA capturing component; b) partitions (3) separating adjacent wells (2) from each other provided that each of said partitions (3) is at least about 10 microns in length from the nearest edge of a first well (2) to the nearest edge of a second well (2') wherein said second well (2') is the nearest neighbor from the first well (2); wherein said floor wall (8) comprises a target capturing element (5) that captures said target (16) and impedes target movement within the
• an assay device (1) comprising a multiplicity of wells (2) aligned thereon wherein each of said wells (2) comprises a) a floor wall (8) and side walls (7) that comprises one or more beads (6) and one or more targets (16) in an aqueous solution (17) wherein the bead or beads (6) in an individual well (2) contains multiple copies of a single compound which are releasably bound to said bead(s) (6) in a dose dependent manner and further wherein each of said beads (6) comprises a RNA capturing component; b) partitions (3) separating adjacent wells (2) from each other provided that each of said partitions (3) is at least about 10 microns in length from the nearest edge of a first well (2) to the nearest edge of a second well (2') wherein said second well (2') is the nearest neighbor from the first well (2); wherein said floor wall (8) comprises a cell capturing element (5) that captures a mammalian cell and impedes cell movement
• the device comprises a well density of at least 10 wells per square millimeter and, preferably, at least about 1,000 to 10,000,000 wells per device.
• a device may comprise at least 1,000 wells, or at least about 10,0000 wells, or at least about 100,000 wells, or at least about 1,000,000 wells.
• each of said partitions (3) is about 20 microns in length from the nearest edge of a first well (2) to the nearest edge of a second well (2') wherein said second well (2') is the nearest neighbor from the first well (2).
• a preferred range of partition (3) lengths is from at least about 10 microns to about 30 microns and preferably from about 15 microns to about 25 microns.
• a single well (2) contains a target or multiple copies of that target (16) optionally in the presence of an aqueous solution (17).
• the target (16) is a mammalian cell and the aqueous solution (17) is a growth medium for that cell so as to maintain the viability of the cell in solution.
• the mammalian cell is a human cell.
• the target (16) is a mammalian cell and the target capturing element (5) comprises a compound (including polymers) that binds to or complexes with the cell so as to impede cell movement within the well.
• a method to inhibit spill-over in an assay device having a high density of wells each of which comprise an aqueous solution comprises: a) providing for a density of wells on said device of at least 10 wells per mm 2 wherein said wells are aligned on the device such that the edge of each of said wells is placed at least about 10 microns from the closest edge of its nearest neighboring well thereby providing for a partition (3) between said wells (2); b) applying to at least a portion of said partitions (3) a biocompatible, hydrophobic water repellent film or layer (4) that overlays the material otherwise comprising the device (1) thereby creating an impediment to transfer of a portion of the aqueous solution in one well (2) to an adjacent well (2).
• a method to impede translocation of a target (16) placed proximate to the middle of the bottom surface of well (2) comprises applying a target capturing element (5) in sufficient amounts so that target (16) translocation is impeded.
• the apparatus may comprise an assay device.
• the assay device may comprise at least 10,000 wells on a top surface of the assay device.
• Each of the at least 10,000 wells may comprise a floor and side walls configured to retain one or more beads and one or more targets in an aqueous solution.
• the assay device may comprise surface partitions separating a first well of the at least 10,000 wells from a second well of the at least 10,000 wells.
• a distance along the top surface of the assay device from a nearest edge of the first well to a nearest edge of the second well may be from about 10 microns (pm) to about 50 pm.
• the second well may be a nearest neighboring well to the first well.
• each of the surface partitions may comprise a hydrophobic layer.
• the hydrophobic layer may be configured to restrict spill-over of the aqueous solution from the first well to the second well.
• the assay device may have a top surface area.
• a density of the at least 10,000 wells on the top surface area may be at least 10 wells per square millimeter (mm 2 ).
• Each of the wells may have a well diameter from about 30 pm to about 250 pm.
• Each of the wells may have a well depth from about 30 pm to about 400 pm.
• the density may be from at least 10 wells per mm2 to about 400 wells per mm2.
• the density may be from about 40 wells per mm2 to about 150 wells per mm2.
• the distance along the top surface from the nearest edge of the first well to the nearest edge of the second well may be from about 10 pm to about 30 pm.
• the apparatus may further comprise a mammalian cell maintained in an aqueous growth medium for the mammalian cell.
• the aqueous growth medium may be configured to maintain the viability of the mammalian cell in solution.
• the aqueous growth medium may be maintained in at least one of the at least 10,000 wells.
• the mammalian cell may be a human cell.
• the target capturing element may comprise poly-D-lysine.
• the distance along the top surface from the nearest edge of the first well to the nearest edge of the second well may be from about 15 pm to about 25 pm.
• the assay device may have at least about 100,000 wells on the top surface.
• the hydrophobic layer may comprise a biologically compatible, hydrophobic material selected from polyethylene, polypropylene, block copolymers of ethylene and propylene, polytetrafluoroethylene, (trichloro)octadecyltsilane (OTS), amorphous fluoropolymers, and polydimethylsiloxane (PDMS).
• a biologically compatible, hydrophobic material selected from polyethylene, polypropylene, block copolymers of ethylene and propylene, polytetrafluoroethylene, (trichloro)octadecyltsilane (OTS), amorphous fluoropolymers, and polydimethylsiloxane (PDMS).
• the floor of at least one of the at least 10,000 wells may further comprise a target capturing element that captures the mammalian cell.
• At least a portion of the floor of at least one of the at least 10,000 wells may be hydrophilic.
• Figure 1 A and Figure IB illustrate a cross-sectional overview of a portion of one embodiment of a device (1) of this invention.
• Figure 1 A is a top view.
• Figure IB is a side view.
• Figures 2A and 2B illustrate a cross-section of a portion of the device (1) described in Figures 1 A and IB wherein the device (1) comprises wells (2), a bead (6) in said well (2), a target capturing element (5) in the well (2), and a hydrophobic water repellent layer (4) forming part of the surface that partitions one well from another.
• Figure 2A shows the leftmost well (2) with a bead (6) disposed therein, while the other two wells (2) middle and rightmost are empty (for clarity).
• Figure 2B shows the device of Figure 2A in which the rightmost well is filled with bead (6), target (16) and solution (17).
• other well (2) content is omitted solely for clarity.
• Figure 2C illustrates a cross-section of another embodiment of a portion of a device (1) described herein wherein the device (1) comprises wells (2), a bead (6) in the well (2), a target capturing element (5) in the well (2), and a hydrophobic water repellant layer (4) extending upward from at least a portion of the partition (3).
• Figure 3 illustrates an optional aspect of this invention where a hydrophobic liquid (18) such as silicon oil is applied to the top of device (1) so as to provide an oil layer over the device thereby further inhibiting spill-over from one well to an adjacent well.
• Figure 3 also shows optional walls (28) extending upward to contain hydrophobic liquid (18).
• Figure 4 illustrates one process for forming the hydrophobic, water repellent layer (4) on the partitions (3) of the assay devices described herein.
• compositions and methods shall mean excluding other elements of any essential significance to the combination for the stated purpose.
• a composition consisting essentially of the elements as defined herein would not exclude other materials or steps that do not materially affect the basic and novel characteristic(s) of the claimed invention.
• Consisting of shall mean excluding more than trace elements of other ingredients and substantial method steps. Embodiments defined by each of these transition terms are within the scope of this invention.
• the term “assay device” refers to a device that is capable of simultaneously assaying multiple test compounds against a target. Such devices contain a multiplicity of wells where each individual well preferably contains multiple copies of substantially the same compound.
• the device comprises a material that transmits light therethrough. For example, the light may be exposed onto the device or the light may be generated from within the device.
• the light transmitted therethrough is at a wavelength and an intensity that at least a portion of the cleavable bonds attaching each of the multiple copies of substantially the same compound to a bead is cleaved from the bead so as to generate a solution having a concentration of that compound in the well.
• the light transmitted therethrough is fluorescence that is generated from molecules in a given well where these molecules are preferably not bound to the bead. As the fluorescence is transmitted through the device, the so generated fluorescence is capable of being detected outside of the device.
• the assay device comprises upwards of 1,000,000 wells and preferably up to about 10,000,000 wells. In one embodiment, the assay device comprises from about 10,000 to about 10,000,000 wells and preferably from about 50,000 to about 2,000,000 wells. In one preferred embodiment, the size of the device is up to about 10,000 square millimeters.
• target means a material such as a biological material that one wishes to assess the binding affinity of a test compound to that target and/or the biological consequences of such binding.
• exemplary targets include monoclonal or polyclonal antibodies, fragments of monoclonal or polyclonal antibodies, mammalian cells, DNA, RNA, siRNA, proteins (e.g., fusion proteins, enzymes, cytokines, chemokines and the like), viruses, and the like.
• the target is a mammalian cell, such as a human cell.
• target capturing element means a biocompatible layer or film of a compound or mixture of compounds.
• the layer or film binds to or complexes with the target on the bottom surface of the well with sufficient strength so as to impede target movement within the well.
• the target capturing element is a biocompatible layer or film that does not interfere with the integrity of a target in suspension or solution.
• the complex between the target and the target capturing element is defined by a dissociation constant (K d ) of less than 1 x 10 3 pmol/pL. In one embodiment when multiple cells are employed in a single well, then the target capturing element further inhibits cell clumping.
• cleavable bonds means that a compound bound to the bead can be released by application of a stimulus that breaks the bond. Such bonds are sometimes referred to as “cleavable” bonds.
• the appropriate stimulus to release the compounds depends on the bond used. The art is replete with examples of such bonds and the appropriate stimulus that breaks the bond.
• Non-limiting examples of cleavable bonds include those that are released by pH changes, enzymatic activity, oxidative changes, redox, UV light, infrared light, ultrasound, changes in magnetic field, to name a few.
• the term “compound,” which is interchangeable with “test compound,” means a compound that is being evaluated for its binding affinity to a target and/or the biological consequences of such binding. Such compounds are typically part of a structure-activity relationship (SAR) analysis as it relates to a specific target. The analysis of what compounds bind or do not bind to the target provides meaningful data to the skilled artisan as to the consequences of changes in the structure of the compound. Likewise, assessing the biological consequences (or activity) of such binding provides still further information to skill artisan as to what structural differences alter these biological consequences. [0058] The term “substantially the same,” used in reference to compounds, means that a majority of the compounds on a bead are the same.
• At least 80% of the compounds are the same and preferably at least 90% and more preferably at least 95%.
• the compounds that are not the same are typically the result of incomplete reactions on the bead such that these compounds are either starting materials or intermediates to the final product. Such compounds are anticipated as lacking sufficient structure to meaningfully interact with the target.
• fluid means a liquid or a flowable powder.
• the term “releasably bound to said bead(s) (6) in a dose dependent manner” means that the compounds are bound to the bead via a cleavable linker, where cleavage is titratable so that the amount of compound released can be controlled.
• the amount of compound released by the cleavable linker is assessed by linkage of multiple copies of a companion marker such as a fluorescent compound bound to the same or different beads by the identical cleavable linker.
• a companion marker such as a fluorescent compound bound to the same or different beads by the identical cleavable linker.
• a non-cleavable quencher molecule is attached proximate thereto to reduce or eliminate fluorescence of that fluorescent compound.
• a standardized plot of fluorescent intensity versus the amount of fluorescent compound cleaved from the bead by the cleaving agent e.g., UV light of a defined wavelength and defined intensity
• UV light is then applied equally to the test bead(s) having cleavable test compounds and to the beads having cleavable fluorescent compounds.
• the extent of cleavage of the fluorescent compounds as evidenced by the standardized plot of fluorescent intensity is then correlated to the amount of test compound released. In such a manner, once can control the amount of test compound released and correlate that to the amount the concentration of the test compound in solution, as the amount of solution per test well is known.
• biocompatible refers to materials that are compatible with each of components used in the devices including without limitation the beads, the targets, the target capturing elements, the compounds, the mRNA, the aqueous solutions employed, and the like.
• the biocompatible materials In the case where the target is a viable cell, the biocompatible materials must maintain the viability of the cells during use.
• the biocompatible materials must retain the functional properties of these components.
• the ability to assay a very large combinatorial library of compounds is limited by the size constraints of the overall device and the density of wells on the device. As the size of the wells decrease, the ability to place more wells on a per square millimeter basis increases. However, there is a limit to such increases as the well integrity requires that there be a minimal distance between adjacent wells. For example, if wells are too close together, a portion of the aqueous solution in one well may spill over to another well rendering the evaluation of both wells suspect. Generally, the minimal distance between wells is at least about 50 microns which ensures that spill over from one well to another is substantially reduced/prevented. However, such a separation distance is contrary to a high density of wells.
• well separation may be less than 50 microns, or less than 40 microns, or less than 30 microns, or less than 20 microns, each with a minimum distance of separation of about 5 microns, or about 10 microns, or about 15 microns, including any values or ranges in between the recited values, including fractions thereof.
• the diameter of each of the wells also controls the density of wells on the device.
• a device having wells with a diameter of about 40 microns can allow for a significantly greater density of wells than a device where the wells are about 150 microns in diameter.
• the devices described herein have a high density of wells, such as those having at least 10 wells per millimeter square of the device surface that comprises wells.
• the device of this invention should be sized for easy use by a skilled technician.
• a conventional 96 well plate is about 128 mm by 85 mm (or about 7.4 inches by 3.3 inches). These plates provide a well density of about 0.00885 wells per mm 2 .
• the devices described herein are contemplated as having a well density of up to about 400 wells per mm 2 and, preferably, at least 10 wells per mm 2 and, more preferably, from about 40 wells per mm 2 to about 150 wells per mm 2 In embodiments, the wells have a well diameter of from about 60 to 150 microns.
• a well density of about 200 wells per mm 2 provides for over 2,100,000 wells when sized to be compatible with a conventional 96 well plate.
• many different device sizes are feasible with a preferred maximum size of from no more than about 12 inches (300 mm - X axis) to no more than about 12 inches (300 mm - Y axis).
• the high well density devices described herein allow for exceptionally high throughput of a combinatorial library.
• FIG. 1 A and IB there is provided an overview illustrating an exemplary portion of the surface of device 1 having a thickness (100) of about 1 mm and where each of the illustrated wells (2) have a maximum diameter (105) (measured along its longest axis) of about 150 microns, a well (2) depth (110) of about 150 microns, and a distance of at least 20 microns from the nearest edge of one well to the nearest edge of a second well that is its nearest neighbor.
• device 1 of Figures 1 A and IB has a top to bottom thickness (100) of at least about 0.1 mm and contains a multiplicity of wells (2) on the surface thereof.
• Each well (2) has a diameter (105) of from about 30 to about 250 microns and preferably from about 50 to about 150 microns.
• Each well (2) has a depth (110) of from about 30 to about 400 microns and preferably about 150 microns. This provides for a volume within the well of 2.65 x 10 6 cubic microns or 0.00265 microliters when the well diameter is about 150 microns and a depth of about 150 microns.
• the devices described herein can comprise any of a number biocompatible, materials including but not limited to polymers such as Cyclo Olefin Polymer (COP) which is commercial available from Zeon Specialty Materials, Inc. (San Jose, California, USA), cyclic olefin copolymers (COC) which are commercially available from a number of sources such as Polyplastics USA, Inc.
• COP Cyclo Olefin Polymer
• COC cyclic olefin copolymers
• the devices of this invention can be readily prepared by hot embossing methods which are well known in the art and comprise stamping a pattern into a polymer softened by heating the polymer to a temperature just above its glass transition temperature. Subsequent cooling of the polymer provides for a high density of wells in the devices described herein.
• mold injection techniques can be used and are well known in the art.
• a solid block of a biocompatible polymer can be laser etched to introduce the desired number of wells having the appropriate size, volume and shape as well as with the desired well density.
• FIGs 1 A and IB illustrate a portion of partially formed device (1) which includes a multiplicity of wells (2) and partitions (3) that separate wells (2) from each other (For an expanded view of partitions (3) see Figures 2A-C).
• each partition (3) is at least about 10 microns in length distant from a first well (2) to its nearest neighboring well (2'). This minimal distance between wells (2) ensures well integrity such that a homogenous aqueous solution (no spill-over) is included in each well (2) and that each well (2) contain one or more beads where the bead(s) contain multiple copies of the same test compound bound thereto.
• the partitions (3) have a length as measured from the nearest neighbor well of about 5, 10 or 20 microns and, more preferably from about 20 microns to less than about 50 microns in length.
• the sheet of thermoplastic polymer is heated to a temperature slightly higher than its glass transition temperature as described above.
• a stamp is selected that comprises a number of circular prongs that are preferably uniformly placed on its surface at a desired density. Each prong is sized to have diameter and a depth correlating to the size of the wells (2) described above. The distance between any two adjacent prongs is at least about 10 microns (i.e., partition (3) is at least about 10 microns thick).
• the stamp is sized so that the portion comprising the prongs fits within the top surface of the sheet.
• the partially formed device (1) of Figures 1 A and IB can be prepared by conventional injection molding using two mold halves - one with protrusions corresponding to those of the stamp (male mold half) and the other forming the base of the device (female mold half).
• the mold halves are juxtaposed to each other so as to form a cavity in the shape of the device (1) illustrated in Figures 1 A and IB.
• Injection of a monomer or reactive oligomer composition into this cavity followed by polymerization provides for a device (1) now containing wells (2) and partitions (3) as per Figures 1 A and IB.
• a silicon dioxide coating may be applied to the top surface of device (1) including a bottom surface (i.e., floor wall of well (2); see Figure 2A) (8) of wells (2) by conventional sputtering technology.
• the thickness of the silicon dioxide layer is from about 0.5 to about 100 nanometers and more preferably about 10 to 50 nanometers.
• the silicon dioxide coating provides a reactive layer that binds both a water repelling, biocompatible layer (4) as well as the target capturing element (5) that are to be formed.
• Figures 2A, 2B, and 2C illustrate different aspects of device (1) during different stages of construction.
• Figure 2A illustrates device (1) having wells (2) with a side surface (7) and a bottom surface (8) as well as a biologically compatible, hydrophobic, water repellant layer (4) defining the top surface of partitions (3).
• a target capturing layer (5) and bead (6) is illustrated in a first well (2).
• Figure 2B further includes target (16) in an aqueous solution (17) in well (2).
• Figure 2C illustrates an alternative form for the biologically compatible, hydrophobic, water repellant layer (4) from that disclosed in Figure 2A.
• water repelling layer (4) is formed only over a portion of the partitions (3) and such can be formed by laser etching the water repelling layer (4) after formation to reduce the length of said partition (4).
• each partition (3) is then modified to include a biologically compatible, hydrophobic, water repellant layer (4) that inhibits spill-over of aqueous solution (17) from one well to another as illustrated in Figure 4.
• the water repelling layer (4) comprises a biologically compatible, hydrophobic, water repellant material such as polyethylene, polypropylene, block copolymers of ethylene and propylene, polytetrafluoroethylene, (trichloro)octadecyltsilane (OTS), amorphous fluoropolymers (such as CYTOP ® ), and polydimethylsiloxane (PDMS), and the like.
• a biologically compatible, hydrophobic, water repellant material such as polyethylene, polypropylene, block copolymers of ethylene and propylene, polytetrafluoroethylene, (trichloro)octadecyltsilane (OTS), amorphous fluoropolymers (such as CYTOP ® ), and polydimethylsiloxane (PDMS), and the like.
• the biocompatible water repellent layer (4) is generated by conventional coating techniques. For example, as illustrated in Step 1 of the process of Figure 4, one such technique involves applying a solution of a biocompatible water repellent material dissolved in a suitable solvent compatible with the device (e.g., ethanol) onto a disc (24). Disc (24) is then spun (not shown) so as to create a thin solution film (23) of about 1-5 microns. The spinning is stopped and then top surface of device (1) is placed onto/into the thin film (23) as shown in Step 2 of Figure 4. Device (1) is disengaged from the disc (24) within about 1 to 5 minutes as shown in Step 3 and then dried to form water repellent layer (4) which is about 1 to 5 microns in thickness.
• a suitable solvent compatible with the device e.g., ethanol
• formation of the water repellent biocompatible layer (4) is then conducted by injection molding to a desired thickness.
• the addition of the water repelling biocompatible layer (4) adds to the depth of each of the wells, it is understood that the total depth of the wells described above refers to that depth after formation of the water repelling layer (4).
• the target capturing element (5) is poly-D- lysine (PDL) which is used for illustrative purposes only. Sufficient PDL is dissolved into an aqueous solution so as to achieve a concentration of, e.g., about 0.1 mg/mL.
• PDL poly-D- lysine
• PDL is commercially available from numerous sources. One preferred source of PDL is from ThermoFisher Scientific, 10010 Mesa Rim Road, San Diego, California USA as catalog no. A389040.
• Other examples of target capturing element (5) include: fibronectin (ThermoFisher Scientific, catalog no. 33016015), vitronectin (Sigma Aldrich, catalog no. 5051), and the like.
• Partially formed device (1) without the PDL target capturing element (5), is immersed into the container comprising the PDL solution as shown in Figure 4, Step 4. The immersion continues for about 1 hour. Device (1) is then removed and then dried as shown in Figure 4, Step E. The hydrophobic coating on the top surface of device (1) inhibits deposition of PDL on that surface thereby providing the target capturing element on the bottom surface (8) of wells (2) and perhaps on the side walls (7) of well (2).
• Target capturing element (5) is biologically compatible with the bottom surface (8) of well (2) and either adheres to the target (17) at the site of deposition so as to impede target translocation once deposited or is biologically compatible with the target (1) when target (1) is in solution or is a suspension.
• the overall character of target capturing element (5) is hydrophilic although areas of hydrophobicity are permitted.
• target capturing element (5) is selected to adhere to the bottom surface (8) of well (2) and to the target (17) deposited thereon.
• Target capturing element (5) includes materials such as poly(amino acids), DNA, RNA, siRNA, antibodies, antibody fragments, proteins, polypeptides, and the like.
• the particular target capturing element (5) is selected relative to the target (16) employed and such a selection is well known to the skilled artisan.
• the target (16) is a mammalian cell, such as a human Hela cell
• the target capturing element (5) is a polymer of D-lysine (PDL).
• PDL D-lysine
• the devices (1) described herein allow for very high densities of wells per square millimeter as well as maintaining reproducible detection of a cell deposited in well (2) using electromagnetic energy detection means (e.g., light).
• electromagnetic energy detection means e.g., light.
• the presence of a water repelling biocompatible layer (4) described herein inhibits or eliminates spill-over of the aqueous solution from adjacent wells.
• the presence of the target capturing element (5) assists in obviating a problem associated with translocation of the target deposited proximate to or at the middle of the bottom of well 2 to its comers. When so translocated, application and reading of electromagnetic energy applied to and retrieved from the target 5 becomes less reliable.
• the target capturing element (5) binds to target (1) that deposits on surface (8) by non-covalent interactions including electrostatic, hydrophilic (e.g., hydrogen bonds), hydrophobic, and Van der Waal forces. Such binding can be measured by an equilibrium disassociation constant (Kd - sometime referred to as KD) where lower values correlate to stronger binding interactions.
• Kd equilibrium disassociation constant
• the target capturing element (5) binds to target (1) with a sufficient disassociation constant so as to impede translocation of target (1) within well (2).
• the binding of the target to the target capturing element provides for a Kd of no more than about 1 x 10 3 and more preferably no more than about 1 x 10 5 pmol/pL.
• the above process provides for a method for forming an assay device (1) wherein said device contains a multiplicity of wells (2).
• This method comprises: a) heating a biocompatible thermoplastic material to just above the glass transition temperature so as to soften the material; b) applying a stamp to the surface of said heated material wherein said stamp contains a number of prongs wherein each prong is sized to have diameter and a depth correlating to the size of the wells (2) to be formed, wherein the distance between any two adjacent prongs is at least about 10 microns; c) applying sufficient pressure to the stamp so as to ensure that the full length of the prongs sink into the sheet and then subsequently removed to provide for wells (2) having partitions (3) separating each well from adjacent wells (2), having a bottom surface (8) and side surface (7); d) optionally applying a layer of silicon dioxide to the exposed surfaces of the partitions (3) and wells (2); e) applying a layer of a biocompatible, water repellent, hydrophobic material (4) to the partition
• the outside edges (28) of device (1) are extended slightly upward to allow for the addition of a layer of hydrophobic fluid (18) which is less dense than water.
• This layer (18) provides for additional protection against spill-over as well as preventing contamination of the wells (2) by contaminants such as dust, pollen, etc. that can affect the test results.
• Hydrophobic fluid 18 is biocompatible and has a density of less than 0.99 grams per cubic centimeter at 25°C so that the fluid forms a layer over the aqueous solution.
• One preferred hydrophobic fluid 18 is silicon oil which is available from many commercial vendors such as SigmaAldrich, Inc., St. Louis, Missouri, USA.
• Hydrophobic fluid 18 can be applied in any manner including by a dispenser that sits over device (1) and applies a mist of the fluid in a manner that does not cause any spill-over of aqueous solution (17) from one well (2) to another well (2).
• One means to provide the hydrophobic fluid layer (18) is provided in US Application No. 16/774,875 entitled “Caps for Assay Devices” (Attorney Docket No. 057698-503F01US).
• a method of preventing spill-over and evaporation comprising providing the device with optional walls (28) and placing hydrophobic liquid (18) over filled wells (2).
• thermoplastic PMMA available from Lucite International Cassel Works, Billingham UK measuring 76 mm (X-axis) by 50 mm (Y-axis) by 1 mm (Z-axis) is heated to a temperature slightly higher than its glass transition temperature (Tg) of about 125°C in order to soften the plastic.
• Tg glass transition temperature
• a stamp is selected that comprises a number of circular prongs uniformly placed into 4 rows on its surface at a density of about 40 prongs per mm 2 in each row. Each row of prongs is approximately 50 mm long and 7 mm wide.
• Each prong has a diameter of about 150 pm and a depth from the base to the end of the prong of about 150 pm. The distance between any two adjacent prongs is about 20 pm.
• the stamp is sized so that each of the rows of prongs fits within the top surface of the sheet. Sufficient force is applied to the stamp so as to ensure that the full length of the prongs sink into the top surface of the sheet. The force required is dependent on the degree of softness of the sheet and is readily ascertainable by the skilled artisan. As the sheet cools, the prongs are removed so as to provide for a partially formed device (1) having wells (2) and partitions (3) as depicted in Figure 1.
• Device (1) having wells (2) and partitions (3) is then coated with a thin layer of silicon dioxide (SiCh) by conventional sputtering technology well known in the art.
• SiCh silicon dioxide
• the sputtering process is continued until a silicon dioxide film of about 30 nanometers in thickness is formed.
• the purpose of this film is used to enhance the adhesion of both the water repelling hydrophobic layer (4) and the target capturing element (5) to device (1).
• Figure 4 illustrates the formation of a water repellent element (3) on the top surface of the partially formed device (1) with the silicon dioxide layer in place.
• a rotatable disc (24) is placed on a spinner and a solution of OTS in ethanol at a concentration of about 25 micromolar is applied thereto.
• the spinner is initiated and rotated at a rate of about 1000 rpm.
• Spinning is continued until the solution (23) is uniformly deposited on the disc.
• spinning is continued for about less than 1 minute and then stopped and the thickness of the solution (23) is about 0.1 microns to about 2 microns.
• Step 2 top surface of partially formed device (1) is placed into the solution (23) on the now stationary disc (24) and maintained there for up to about 5 minutes.
• Step 3 partially formed device (1) is removed from the disc and then dried to form water repellent layer (4) which is about 1 to 2 microns in thickness.
• Step 4 illustrates the formation of the target capturing element (6) on the bottom surface of wells (2).
• a container (25) is filled with a solution (26) of poly-D-lysine obtained from ThermoFisher Scientific, 10010 Mesa Rim Road, San Diego, California USA as catalog no. A389040.
• Sufficient PDL is dissolved into an aqueous solution so as to achieve a concentration of, e.g., about 0.1 mg/mL.
• a concentration of, e.g., about 0.1 mg/mL e.g., about 0.1 mg/mL.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Immunology (AREA)
• Engineering & Computer Science (AREA)
• Molecular Biology (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Organic Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Urology & Nephrology (AREA)
• Biochemistry (AREA)
• Analytical Chemistry (AREA)
• Medicinal Chemistry (AREA)
• Biotechnology (AREA)
• Microbiology (AREA)
• Physics & Mathematics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Cell Biology (AREA)
• Food Science & Technology (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Toxicology (AREA)
• General Chemical & Material Sciences (AREA)
• Tropical Medicine & Parasitology (AREA)
• Biophysics (AREA)
• General Engineering & Computer Science (AREA)
• Genetics & Genomics (AREA)
• Clinical Laboratory Science (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)
• Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=83640933

Family Applications (1)

Country Status (7)

Family Cites Families (2)

• 2021
  • 2021-04-16 WO PCT/US2021/027769 patent/WO2022220844A1/en active Application Filing
  • 2021-04-16 IL IL307630A patent/IL307630A/en unknown
  • 2021-04-16 KR KR1020237038237A patent/KR20240013103A/ko active Search and Examination
  • 2021-04-16 EP EP21937166.3A patent/EP4323100A1/en active Pending
  • 2021-04-16 CN CN202180098630.5A patent/CN117440860A/zh active Pending
  • 2021-04-16 CA CA3220131A patent/CA3220131A1/en active Pending
  • 2021-04-16 JP JP2023563097A patent/JP2024516375A/ja active Pending

Also Published As

Similar Documents

Legal Events